Antonio Marchesoni

Summary

Affiliation: University of Milan
Country: Italy

Publications

  1. ncbi request reprint Step-down approach using either cyclosporin A or methotrexate as maintenance therapy in early rheumatoid arthritis
    Antonio Marchesoni
    G Pini Orthopaedic Institute, Milan, Italy
    Arthritis Rheum 47:59-66. 2002
  2. doi request reprint Entheseal power Doppler ultrasonography: a comparison of psoriatic arthritis and fibromyalgia
    Antonio Marchesoni
    UOC Day Hospital of Rheumatology and Division of Rheumatology, G Pini Orthopedic Institute, Milan, Italy
    J Rheumatol Suppl 89:29-31. 2012
  3. doi request reprint Classification and clinical assessment
    A Marchesoni
    UO Day Hospital di Reumatologia, Istituto Ortopedico G Pini, Milano
    Reumatismo 64:79-87. 2012
  4. doi request reprint Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia
    Antonio Marchesoni
    UOC Day Hospital of Rheumatology, Istituto Ortopedico Gaetano Pini, Piazza A Ferrari 1, 20122 Milan, Italy
    J Rheumatol 39:849-55. 2012
  5. ncbi request reprint An Italian shared dermatological and rheumatological proposal for the use of biological agents in psoriatic disease
    A Marchesoni
    UOC DH of Rheumatology, G Pini Orthopaedic Institute, Milan, Italy
    J Eur Acad Dermatol Venereol 24:578-86. 2010
  6. ncbi request reprint Radiographic progression in early rheumatoid arthritis: a 12-month randomized controlled study comparing the combination of cyclosporin and methotrexate with methotrexate alone
    A Marchesoni
    Rheumatology Department, University of Milan, Italy
    Rheumatology (Oxford) 42:1545-9. 2003
  7. doi request reprint Multidisciplinary focus on methotrexate in psoriatic disesase
    Antonio Marchesoni
    U O C Day Hospital of Rheumatology, G Pini Orthopaedic Institute, 20122 Milan, Italy
    J Rheumatol Suppl 83:56-8. 2009
  8. doi request reprint TNF-alpha antagonist survival rate in a cohort of rheumatoid arthritis patients observed under conditions of standard clinical practice
    Antonio Marchesoni
    Day Hospital of Rheumatology, G Pini Orthopaedic Institute, Milan, Italy
    Ann N Y Acad Sci 1173:837-46. 2009
  9. ncbi request reprint The Italian registry of aggressive rheumatoid arthritis -- the GIARA project
    Antonio Marchesoni
    UOC Rheumatology Day Hospital, G Pini Orthopaedic Institute, University of Milan, Milan, Italy
    J Rheumatol 34:2374-81. 2007
  10. ncbi request reprint Predicting response to anti-TNF treatment in rheumatoid arthritis patients
    Fabiola Atzeni
    Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Autoimmun Rev 8:431-7. 2009

Collaborators

Detail Information

Publications20

  1. ncbi request reprint Step-down approach using either cyclosporin A or methotrexate as maintenance therapy in early rheumatoid arthritis
    Antonio Marchesoni
    G Pini Orthopaedic Institute, Milan, Italy
    Arthritis Rheum 47:59-66. 2002
    ....
  2. doi request reprint Entheseal power Doppler ultrasonography: a comparison of psoriatic arthritis and fibromyalgia
    Antonio Marchesoni
    UOC Day Hospital of Rheumatology and Division of Rheumatology, G Pini Orthopedic Institute, Milan, Italy
    J Rheumatol Suppl 89:29-31. 2012
    ..To compare the power Doppler ultrasonography (PDUS) pictures of peripheral entheses in patients with psoriatic arthritis (PsA) and fibromyalgia (FM)...
  3. doi request reprint Classification and clinical assessment
    A Marchesoni
    UO Day Hospital di Reumatologia, Istituto Ortopedico G Pini, Milano
    Reumatismo 64:79-87. 2012
    ..Finally, composite indices that capture several clinical manifestations of PsA have been proposed and a new instrument, the Psoriatic ARthritis Disease Activity Score (PASDAS), is currently being developed...
  4. doi request reprint Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia
    Antonio Marchesoni
    UOC Day Hospital of Rheumatology, Istituto Ortopedico Gaetano Pini, Piazza A Ferrari 1, 20122 Milan, Italy
    J Rheumatol 39:849-55. 2012
    ..To identify the clinical features that can help to distinguish between psoriatic arthritis (PsA) and fibromyalgia (FM)...
  5. ncbi request reprint An Italian shared dermatological and rheumatological proposal for the use of biological agents in psoriatic disease
    A Marchesoni
    UOC DH of Rheumatology, G Pini Orthopaedic Institute, Milan, Italy
    J Eur Acad Dermatol Venereol 24:578-86. 2010
    ..As psoriatic disease (PD) is a condition characterized by the combination of inflammatory skin (psoriasis) and osteo-articular manifestations (psoriatic arthritis), its treatment should cover both its clinical components...
  6. ncbi request reprint Radiographic progression in early rheumatoid arthritis: a 12-month randomized controlled study comparing the combination of cyclosporin and methotrexate with methotrexate alone
    A Marchesoni
    Rheumatology Department, University of Milan, Italy
    Rheumatology (Oxford) 42:1545-9. 2003
    ..To determine whether patients with early rheumatoid arthritis (RA) treated with cyclosporin A (CsA) and methotrexate (MTX) in combination for 12 months show a lower rate of radiographic deterioration than those treated with MTX alone...
  7. doi request reprint Multidisciplinary focus on methotrexate in psoriatic disesase
    Antonio Marchesoni
    U O C Day Hospital of Rheumatology, G Pini Orthopaedic Institute, 20122 Milan, Italy
    J Rheumatol Suppl 83:56-8. 2009
    ....
  8. doi request reprint TNF-alpha antagonist survival rate in a cohort of rheumatoid arthritis patients observed under conditions of standard clinical practice
    Antonio Marchesoni
    Day Hospital of Rheumatology, G Pini Orthopaedic Institute, Milan, Italy
    Ann N Y Acad Sci 1173:837-46. 2009
    ..Comorbidities, increasing DAS28 values and co-therapy with methotrexate were associated with a lower risk of discontinuation...
  9. ncbi request reprint The Italian registry of aggressive rheumatoid arthritis -- the GIARA project
    Antonio Marchesoni
    UOC Rheumatology Day Hospital, G Pini Orthopaedic Institute, University of Milan, Milan, Italy
    J Rheumatol 34:2374-81. 2007
    ..In 1999, the Italian Society of Rheumatology started a project to determine the prevalence and clinical characteristics of aggressive rheumatoid arthritis (ARA)...
  10. ncbi request reprint Predicting response to anti-TNF treatment in rheumatoid arthritis patients
    Fabiola Atzeni
    Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Autoimmun Rev 8:431-7. 2009
    ..To identify the clinical factors predicting failure or a good clinical response in the cohort of RA patients entered in the Lombardy Rheumatology Network (LORHEN) registry after 3 years of treatment with anti-TNF agents...
  11. doi request reprint Serious infections during anti-TNFalpha treatment in rheumatoid arthritis patients
    Ennio Giulio Favalli
    UOC Day Hospital of Rheumatology, G Pini Orthopedic Institute, University of Milan, Milan, Italy
    Autoimmun Rev 8:266-73. 2009
    ..014), and the concomitant use of corticosteroids (p=0.029) as significant predictors of infections. There was no statistically significant difference in risk between the anti-TNFalpha agents...
  12. doi request reprint Tumour necrosis factor antagonist therapy and cancer development: analysis of the LORHEN registry
    Francesca Bobbio Pallavicini
    Rheumatology Department, IRCCS Policlinico S Matteo, University of Pavia, Pavia, Italy
    Autoimmun Rev 9:175-80. 2010
    ..The objective was to compare cancer risk in a RA cohort population treated with TNF antagonists, and identify the characteristics of the patients at higher risk...
  13. doi request reprint Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry
    Fabiola Atzeni
    Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Autoimmun Rev 12:225-9. 2012
    ..To evaluate the risk of serious infections (SIs) in RA patients receiving anti-TNF therapy on the basis of the data included in the GISEA register...
  14. doi request reprint Switching rheumatoid arthritis treatments: an update
    Fabiola Atzeni
    Rheumatology Unit, L Sacco University Hospital, Milan, Italy
    Autoimmun Rev 10:397-403. 2011
    ..However, many RA patients can be successfully treated with a second TNF antagonist, especially those discontinuing the first because of secondary failure or adverse events...
  15. ncbi request reprint Treatment of psoriatic arthritis and rheumatoid arthritis with disease modifying drugs -- comparison of drugs and adverse reactions
    Philip S Helliwell
    Academic Unit of Musculoskeletal and Rehabilitation Medicine, University of Leeds, Leeds, UK
    J Rheumatol 35:472-6. 2008
    ..Although it seems likely that these conditions have a different pathogenesis, the drugs used to treat them are the same. Our study used a cross-sectional clinical database to compare drug use and side-effect profile in these 2 diseases...
  16. ncbi request reprint Polymorphism in the matrix metalloproteinase-1 promoter gene and severity of rheumatoid arthritis
    Marco Massarotti
    J Rheumatol 29:2241; author reply 2242. 2002
  17. ncbi request reprint Antibodies to cyclic citrullinated peptides in psoriatic arthritis: do classification criteria affect study results?
    Antonio Marchesoni
    J Rheumatol 33:435; author reply 436-7. 2006
  18. ncbi request reprint A comparison of the performance characteristics of classification criteria for the diagnosis of psoriatic arthritis
    William J Taylor
    Rheumatology and Rehabilitation Research Unit, University of Leeds, UK
    Semin Arthritis Rheum 34:575-84. 2004
    ..To compare the accuracy of published classification criteria for the diagnosis of psoriatic arthritis (PsA) and to see whether data-derived classification criteria would be more accurate...
  19. ncbi request reprint Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis
    Ennio Giulio Favalli
    Arthritis Rheum 51:301-2. 2004
  20. ncbi request reprint Polymorphism in the stromelysin 1 (matrix metalloproteinase 3) promoter gene and severity of rheumatoid arthritis: comment on the article by Constantin et al
    Marco Massarotti
    Arthritis Rheum 48:2695-6. 2003